5 assets in Kidney Disorder

Therapeutic assets addressing Kidney Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Volitinib Kidney Disorder	AstraZeneca	P3	B (60)
NKT2152 Kidney Disorder	NiKang Therapeutics, Inc.	P2	CCC (53)
Palbociclib Kidney Disorder	NiKang Therapeutics, Inc.	P2	CCC (53)
Sasanlimab Kidney Disorder	NiKang Therapeutics, Inc.	P2	C (34)
Acetylcysteine Kidney Disorder	Fakultas Kedokteran Universitas Indonesia	P2/3	NR ()